167 related articles for article (PubMed ID: 26084625)
1. Kaposiform Haemangioendothelioma-spectrum Lesions with Kasabach-Merritt Phenomenon: Retrospective Analysis and Long-term Outcome.
Boccara O; Fraitag S; Lasne D; Fontaine J; Bughin V; Hamel-Teillac D; Orbach D; Brunelle F; de Prost Y; Hadj-Rabia S; Bodemer C
Acta Derm Venereol; 2016 Jan; 96(1):77-81. PubMed ID: 26084625
[TBL] [Abstract][Full Text] [Related]
2. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon.
Fernandez-Pineda I; Lopez-Gutierrez JC; Chocarro G; Bernabeu-Wittel J; Ramirez-Villar GL
Pediatr Blood Cancer; 2013 Sep; 60(9):1478-81. PubMed ID: 23609996
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns.
Garcia-Monaco R; Giachetti A; Peralta O; Napoli N; Lobos P; Gioseffi L; Mariani G
J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299
[TBL] [Abstract][Full Text] [Related]
5. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
[TBL] [Abstract][Full Text] [Related]
6. Treating kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon by intralesional injection of absolute ethanol.
Shen W; Cui J; Chen J; Zou J; Xiaoying Z
J Craniofac Surg; 2014 Nov; 25(6):2188-91. PubMed ID: 25318440
[TBL] [Abstract][Full Text] [Related]
7. Mediastinal kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a patient with no skin changes and a normal chest CT.
Wallenstein MB; Hole MK; McCarthy C; Fijalkowski N; Jeng M; Wong WB
Pediatr Hematol Oncol; 2014 Sep; 31(6):563-7. PubMed ID: 24047193
[TBL] [Abstract][Full Text] [Related]
8. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
Ji Y; Yang K; Peng S; Chen S; Xiang B; Xu Z; Li Y; Wang Q; Wang C; Xia C; Li L; Liu X; Lu G; Yang G; Wu H
Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
[TBL] [Abstract][Full Text] [Related]
9. [Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
Korsaga-Somé N; Maruani A; Abdo I; Favrais G; Lorette G
Ann Dermatol Venereol; 2015 Oct; 142(10):578-80. PubMed ID: 25999262
[No Abstract] [Full Text] [Related]
10. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
11. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262
[TBL] [Abstract][Full Text] [Related]
12. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence?
Ji Y; Chen S; Yang K; Xia C; Peng S
J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Corticosteroid-Resistant Vascular Tumors Associated with the Kasabach-Merritt Phenomenon in Infants: An Approach with Transcatheter Arterial Embolization Plus Vincristine Therapy.
Tan X; Chen M; Zhang J; Zhou S; Shen G; Liu Z; Jiang H; Xia J
J Vasc Interv Radiol; 2016 Apr; 27(4):569-75. PubMed ID: 26898623
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
15. Kasabach-Merritt phenomenon: a report of 11 cases from a single institution.
Yasui N; Koh K; Kato M; Park MJ; Tomizawa D; Oshima K; Uchisaka N; Gocho Y; Arakawa A; Seki M; Oguma E; Kishimoto H; Watanabe S; Kikuchi A; Hanada R
J Pediatr Hematol Oncol; 2013 Oct; 35(7):554-8. PubMed ID: 23389504
[TBL] [Abstract][Full Text] [Related]
16. Kaposiform hemangioendothelioma without cutaneous involvement.
Ji Y; Chen S; Li L; Yang K; Xia C; Li L; Yang G; Kong F; Lu G; Liu X
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2475-2484. PubMed ID: 30293120
[TBL] [Abstract][Full Text] [Related]
17. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma.
Croteau SE; Gupta D
Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323
[TBL] [Abstract][Full Text] [Related]
18. How we use angiopoietin-2 in the diagnosis and management of vascular anomalies.
Engel ER; Le Cras TD; Ricci KW
Pediatr Blood Cancer; 2024 May; 71(5):e30921. PubMed ID: 38439088
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study on the outcomes of infantile tufted angioma complicated by Kasabach-Merritt Phenomenon.
Lei HZ; Sun B; Ma YC; Li MM; Wang LF; Jiang SW; Huo R; Dong CX
Clin Chim Acta; 2018 Nov; 486():199-204. PubMed ID: 30096317
[TBL] [Abstract][Full Text] [Related]
20. Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon.
Martyanov AA; Tesakov IP; Khachatryan LA; An OI; Boldova AE; Ignatova AA; Koltsova EM; Korobkin JD; Podoplelova NA; Svidelskaya GS; Yushkova E; Novichkova GA; Eble JA; Panteleev MA; Kalinin DV; Sveshnikova AN
Blood Adv; 2023 Sep; 7(17):4936-4949. PubMed ID: 37307200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]